ranitidine has been researched along with Esophagitis, Peptic in 175 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 68 (38.86) | 18.7374 |
1990's | 85 (48.57) | 18.2507 |
2000's | 19 (10.86) | 29.6817 |
2010's | 3 (1.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hrycevych, N; Pshyk-Titko, I; Savytska, M; Zayachkivska, O | 1 |
Dağli, ET; Kirazli, Ö; Özkan, M; Şehirli, ÜS; Tuğtepe, H; Verimli, U | 1 |
Kasiwong, S; Mahattanadul, S; Nima, S; Phdoongsombut, N; Ratanasuwon, P; Ridtitid, W | 1 |
Chejfec, G; Greenlee, H; Khandelwal, S; Miller, T; Nemchausky, B; O'Connell, S; Schnell, T; Seidel, J; Sonnenberg, A; Sontag, SJ | 1 |
Baik, SK; Cho, MY; Kim, HS; Kim, JM; Kim, JW; Kwon, SO; Lee, DK; Suk, KT | 1 |
Han, SY; Jee, SR; Kim, DH; Lee, JT; Park, SJ; Seol, SY; Urm, SH | 1 |
Habu, Y; Hayakumo, T; Hayashi, K; Kawai, K; Kusuda, T; Maeda, K; Shio, S; Watanabe, Y; Yamazaki, M; Yoshino, T | 1 |
Baek, JT; Chung, IK; Jeong, HY; Kim, AN; Kim, SH; Kim, SJ; Lee, BS; Lee, DS; Lee, GS; Lee, JM; Lee, SH; Lee, TY; Nam, SW; Oh, JI; Shin, JE; Sung, JK; Yoon, SJ | 1 |
Corkins, MR; Croffie, JM; Eckert, GJ; Fitzgerald, JF; Gupta, SK; Molleston, JP; Pfefferkorn, MD | 1 |
Guda, N; Partington, S; Vakil, N | 1 |
Boccia, G; Buonavolontà, R; Manguso, F; Miele, E; Staiano, A | 1 |
Hassall, E | 1 |
Hotz, J | 1 |
Kimmig, JM | 1 |
Koelz, HR | 1 |
Doyle, GD; Fielding, JF | 1 |
Wesdorp, IC | 2 |
Biglioli, P; Dettori, G; Marongiu, G; Muscas, A; Niolu, P; Noya, G; Spirito, R | 1 |
Berstad, A | 1 |
Gubernatis, G; Siewert, JR; Weiser, HF | 1 |
Pounder, RE | 1 |
Rösch, W | 1 |
Potter, PH; Westby, RG | 1 |
Blum, AL; Caradonna, P; Fimmel, CJ; Pace, F; Sabbatini, F | 1 |
Birchler, R; Blum, AL; Bron, B; Delmore, G; Frey, M; Gonvers, JJ; Halter, F; Hammer, B; Koelz, HR; Miller, G; Realini, S | 1 |
Ballarin, E; Comin, U; Guslandi, M; Marchi, R; Masci, E; Passaretti, S; Ronchi, G; Testoni, PA; Tittobello, A | 1 |
Dekker, W; Klinkenberg-Knol, EC; Wesdorp, IC | 1 |
Goy, JA; Maynard, JH; McNaughton, WM; O'Shea, A | 1 |
de Carle, D | 1 |
Friedman, LS; Isselbacher, KJ; Zeldis, JB | 1 |
Barbara, L; Dobrilla, G | 1 |
Fairclough, PD; Hine, KR; Holmes, GK; Lucey, M; Melikian, V | 1 |
Mainguet, P | 1 |
Badalamenti, S; Battaglia, G; Di Mario, F; Leandro, G; Mela, GS; Pantalena, M; Pilotto, A; Savarino, V; Termini, R; Vigneri, S | 1 |
Barbier, JP; Bergmann, JF; Hamelin, B | 1 |
Bardhan, KD; Brocklebank, D; Hawkey, CJ; Long, RG; Morgan, AG; Moules, IK; Wormsley, KG | 1 |
Carlsson, R; Eriksson, S; Långström, G; Naesdal, J; Rikner, L | 1 |
Avner, D; Greski-Rose, PA; Jennings, DE; Jhala, N; Robinson, M; Sahba, B | 1 |
Meshkinpour, H | 1 |
Classen, M; Dammann, HG; Koop, H; Lühmann, R; Schepp, W; Schneider, A | 1 |
Kane, R; Karjoo, M | 1 |
Boros, I; Keszler, P; Pósch, E; Szombath, D | 1 |
Carling, L; Edwin, B; Glise, H; Hallerbäck, B; Havu, N; Lundberg, K; Lyrenäs, E; Unge, P | 1 |
James, OF; Parry-Billings, KS | 1 |
Feldman, M; Fisher, RS; Greski-Rose, PA; Harford, WV; Jennings, DE; Murray, SB; Sampliner, RE | 1 |
Colin-Jones, DG; Singh, P; Taylor, RH | 1 |
Bunke, R; Hotz, J; Plein, K | 1 |
Stålhammar, NO | 1 |
Armstrong, D; Bettschen, HU; Blum, AL; Emde, C; Halter, F; Huber, T; Inauen, W; Merki, HS; Scheurer, U; Weber, B | 1 |
Dent, J; Hetzel, DJ; Mackinnon, M; Narielvala, FM; Reed, W; Shearman, DJ; Solcia, E; Yeomans, ND | 1 |
Geldof, H; Hazelhoff, B; Otten, MH | 1 |
Fraser, AG; Hudson, M; Pounder, RE; Sawyerr, AM; Smith, M | 1 |
Auricchio, S; Campanozzi, A; Cucchiara, S; D'Armiento, F; Franceschi, M; Franco, MT; Iervolino, C; Minella, R | 1 |
Collen, MJ; Johnson, DA; Sheridan, MJ | 1 |
Andres, JM; Baron, TH; Richter, JE; Singh, S; Tennyson, GS | 1 |
Decktor, DL; Kogut, D; Maton, PN; McCullough, A; Pardoll, P; Roberts, W; Robinson, M; Roufail, W; Sabesin, S; Saco, L | 1 |
Berstad, A; Hatlebakk, JG | 2 |
Berlin, RG; Gilde, L; Simon, TJ; Tipping, R | 1 |
Grey, MR | 1 |
Goodwin, C; McKenna, CJ; Mills, JG; Wood, JR | 1 |
Bischof, G; Feil, W; Riegler, M; Schiessel, R; Wenzl, E | 1 |
Collen, MJ; Kerr, RM; Kogut, DG; Richter, JE; Sabesin, SM; Wruble, LD | 1 |
Kahrilas, PJ; Pouderoux, P | 1 |
Cooper, BT; Fosters, CS; Garrett, AD; Gough, AL; Langworthy, CH; Long, RG | 1 |
Ansel, HJ; Farahmand, M; Ho, SB; Johnson, JA; Silvis, SE | 1 |
Geus, WP; Lamers, CB; Mulder, PG; Smout, AJ; Stockbrügger, RW | 1 |
Lambert, R | 1 |
Brennenstuhl, M; Hammar, CH; Jaspersen, D; Raschka, C; Schorr, W; Schwacha, H | 1 |
Lamers, CB | 2 |
Campbell, DR; Castell, D; Fleischmann, R; Kogut, DG; Lehman, GA; McFarland, M; Richter, J; Robinson, M; Sabesin, S; Sontag, SJ | 1 |
Kinoshita, M; Saito, N; Tamaki, H | 1 |
Fölsch, UR; Katsoulis, S | 1 |
Abucar, A; Armbrecht, U; Hameeteman, W; Schneider, A; Stockbrügger, RW | 1 |
Harris, RA; Kuppermann, M; Richter, JE | 1 |
Bardhan, KD; Bishop, A; Brooks, A; Cherian, P; D'Silva, J; Gillon, KR; Jones, RB; Manek, S; Morris, P; Parkin, S; Patterson, J; Polak, J; Thompson, M; Vaishnavi, A | 1 |
King, VJ | 1 |
Dettmer, A; Fischer, R; Lühmann, R; Schneider, A; Sielaff, F; Vogt, R | 1 |
Frampton, JE; McTavish, D | 1 |
Bloom, BS | 1 |
Festen, HP; Nelis, F; Schenk, E; Snel, P; Tan, G | 1 |
Berstad, A; Hatlebakk, JG; Olafsson, S; Wilhelmsen, I | 1 |
Jansen, JB; Van Oene, JC | 1 |
Aralica, G; Deskovic, S; Gjurasin, M; Grabarevic, Z; Hanzevacki, M; Jadrijevic, S; Jagic, V; Kocman, B; Miklic, P; Mikus, D; Mise, S; Patrlj, L; Perovic, D; Petek, M; Rotkvic, I; Rucman, R; Sarlija, M; Sebecic, B; Seiwerth, S; Separovic, J; Sikiric, P; Sosa, T; Turkovic, B; Ziger, T; Zoricic, I | 1 |
Bethke, T; de K Grundling, H; Fischer, R; O'Keefe, SJ; Retief, FJ; Theron, I; van Rensburg, CJ; van Zyl, JH | 1 |
Habu, Y; Inokuchi, H; Kawai, K; Kiyota, K; Oyasu, K; Sumitomo, Y; Wakamatsu, T | 1 |
Larson, LR; Ofman, JJ; Siddique, RM; Willian, MK; Yamashita, BD | 1 |
Ahn, BO; Cho, H; Cho, SW; Hahm, KB; Kim, WB; Kim, YB; Lee, JS; Oh, TY; Surh, YJ | 1 |
Bardou, M | 1 |
Adamek, RJ; Behrendt, J; Wenzel, C | 1 |
Ahn, BO; Cho, H; Hahm, KB; Kim, HJ; Kim, WB; Kim, YB; Lee, JS; Oh, TY; Surh, YJ | 1 |
Ahn, BO; Cho, H; Cho, SW; Hahm, KB; Kim, WB; Kim, YB; Lee, JS; Lee, KM; Oh, TY; Surh, YJ | 1 |
Adachi, K; Kinoshita, Y | 1 |
Almeida, JR; Boaventura, S; Castro, LP; Ferrari, AP; Fischer, R; Haddad, MT; Jorge, JL; Leitão, O; Magalhães, AF; Maguilnik, I; Meneghelli, UG; Moraes-Filho, JP; Silva, E; Tolentino, M | 1 |
Hetzel, DJ | 1 |
Joelson, IB; Joelson, S; Lundborg, P; Walan, A; Wallander, MA | 1 |
Jaup, BH | 1 |
Johnson, NJ; Londong, W; Phillips, J; Wood, JR | 1 |
Jönsson, B; Lindberg, G | 2 |
Bender, SW | 1 |
Bianchi Porro, G; Bonavina, L; Franceschi, M; Pace, F; Peracchia, A; Scialabba, A; Vigneri, S | 1 |
Chopra, BK; Kazal, HL; Mittal, PK; Sibia, SS | 2 |
Franz, E; Sewing, KF | 1 |
Dekker, W; Dekkers, CP; Schotborgh, RH; Schrijver, M; Tytgat, GN; van Olffen, GH; vd Boomgaard, DM; Vermeijden, JR; Vosmaer, GD | 1 |
Collen, MJ; Strong, RM | 1 |
Funch Jensen, P; Jensen, SL | 1 |
Farup, PG; Modalsli, B; Tholfsen, JK | 1 |
Backman, L; Ekström, P; Enander, LK; Falkmer, S; Fausa, O; Grimelius, L; Havu, N; Lind, T; Lönroth, H; Lundell, L | 1 |
Cederberg, C; Idström, JP; Lind, T; Lönroth, H; Lundell, L; Olbe, L | 1 |
Bremner, CG; Marks, IN; Segal, I; Simjee, A | 1 |
Stocky, A | 1 |
Bianchi Porro, G; Pace, F; Sangaletti, O | 4 |
Backman, L; Ekström, P; Enander, LH; Fausa, O; Lind, T; Lönroth, H; Lundell, L; Sandmark, S; Sandzén, B; Unge, P | 1 |
Bianchi Porro, G; Pace, F; Sangaletti, O; Zhu, H | 1 |
Brunner, GH; Creutzfeldt, W; Lamberts, R | 1 |
Lundell, L | 1 |
Janisch, HD | 1 |
Bode, JC; Klotz, U; Meinke, J; Treiber, G; Walker, S | 1 |
Fiorucci, S; Morelli, A; Santucci, L | 1 |
Jansen, JB; Lamers, CB | 1 |
Edge, DP | 1 |
Halvorsen, L; Johnson, NJ; Lee, FI; Mills, JG; Wesdorp, IC; Wood, JR | 1 |
Brunner, G; Creutzfeldt, W | 1 |
Boyd, EJ; Johnson, NJ; Mills, JG; Wood, JR | 1 |
Bode, JC; Klotz, U; Krishna, DR; Walker, S | 1 |
Collette, RP; Maydonovitch, CL; McNally, PR; Prosek, RA; Wong, RK | 1 |
Armentano, G; Bracco, PL; Di Silverio, C | 1 |
Dammann, HG; Müller, P; Simon, B | 1 |
Barbier, P; Carlsson, R; Eriksson, S; Isal, JP; Rampal, P; Zeitoun, P | 1 |
Sölvell, L | 1 |
Zeitoun, P | 1 |
Bordas, JM; Grande, L; Pujol, A; Ros, E | 1 |
Duan, ZB | 1 |
Festen, HP; Jansen, JM; Klinkenberg-Knol, EC; Lamers, CB; Meuwissen, SG | 1 |
Desjars De Keranroué, N; Isal, JP; Zeitoun, P | 1 |
Beats, BC; Gill, TR; Gordon, PC; Hadley, N; Harvey, RF; Long, DE; Macpherson, RI; Tottle, AJ | 1 |
Arnold, R; Koop, H | 1 |
Nio, CY; Tytgat, GN | 1 |
Klinkenberg-Knol, EC; Meuwissen, SG | 1 |
Pignon, JP | 1 |
Festen, HP; Klinkenberg-Knol, EC; Meuwissen, SG | 1 |
Carlsson, R; Fausa, O; Lundell, L; Sandmark, S | 1 |
Bouzo, MH; Hüttemann, W; Janisch, HD | 1 |
Lieberman, DA | 1 |
Andersen, BN; Fenger, C; Hanberg-Sørensen, F; Havelund, T; Jensen, KB; Lauritsen, K; Laursen, LS; Pedersen, SA; Skoubo-Kristensen, E | 1 |
Arnold, R; Bauer, A; Klein, M; Koop, H | 1 |
Coenegrachts, JL; Rutgeerts, L; Schurmans, P; Vantrappen, G | 1 |
Barwick, KW; McCallum, RW; Nardi, R; Robinson, M; Sontag, S | 1 |
Mueller, P; Simon, B | 1 |
Baldi, F; Barbara, L; Boero, A; Bovero, E; Camarri, E; Cheli, R; Corradini, P; Dobrilla, G; Mura, GC; Piazzi, L | 1 |
Angeloni, M; Baldi, F; Barbara, L; Ferrarini, F; Longanesi, A; Miglioli, M; Ragazzini, M | 1 |
Brunner, G; Creutzfeldt, W; Harke, U; Lamberts, R | 1 |
Andersen, JR; Christoffersen, P; Kaas-Claesson, N; Tønnesen, H | 1 |
Berger, J; Blum, AL; Dammann, HG; Lux, G; Rehner, M; Riecken, EO; Schiessel, R; Wienbeck, M; Witzel, L | 1 |
Blum, AL; Dammann, HG; Lux, G; Rehner, M; Riecken, EO; Schiessel, R; Wienbeck, M; Witzel, L | 1 |
Krekelä, I; Lehtola, J; Martikainen, J; Niemelä, S | 1 |
Birchler, R; Bretholz, A; Bron, B; Capitaine, Y; Delmore, G; Fehr, HF; Fumagalli, I; Gehrig, J; Gonvers, JJ; Koelz, HR | 1 |
Rohner, HG; Wienbeck, M | 1 |
Anand, BS; Balakrishnan, V; Desai, D; Habibullah, CM; Joshi, VG; Kalro, RH; Misra, RC; Nigam, DK; Parikh, KN; Puri, DS | 1 |
Bianchi Porro, G; Lazzaroni, M; Pace, F | 1 |
Aldersley, MA; Lloyd, RS; Robertson, DA; Shepherd, H; Smith, CL | 1 |
Hüttemann, W; Pelz, W; Rohner, HG; Wienbeck, M | 1 |
Desmond, P; Henderson, M; Vellar, D; Vellar, ID | 1 |
Nelis, GF | 1 |
Andersen, B; Axelsson, CK; Bekker, C; Grove, O; Jeppe-Hansen, MG; Karstoft, E; Nielsen, HO; Rask-Madsen, J; Sanchez, G | 1 |
Guslandi, M; Masci, E; Passaretti, S; Testoni, PA; Tittobello, A | 1 |
20 review(s) available for ranitidine and Esophagitis, Peptic
Article | Year |
---|---|
Histamine H2-receptor antagonists and gastric acid secretion.
Topics: Burimamide; Chemical Phenomena; Chemistry; Cimetidine; Duodenal Ulcer; Esophagitis, Peptic; Gastric Acid; Gastrins; Gastrointestinal Hemorrhage; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Hypersensitivity; Intrinsic Factor; Kinetics; Malabsorption Syndromes; Metiamide; Pancreas; Pepsin A; Ranitidine; Receptors, Histamine H2; Stomach Ulcer; Stress, Psychological; Zollinger-Ellison Syndrome | 1984 |
[New ulcer drugs: is cimetidine out of date?].
Topics: Aluminum; Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Esophagitis, Peptic; Furans; Guanidines; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage; Ranitidine; Stress, Physiological; Sucralfate | 1982 |
Ranitidine: a new H2-receptor antagonist.
Topics: Cimetidine; Drug Resistance; Esophagitis, Peptic; Gastric Acid; Gastrointestinal Hemorrhage; Humans; Kinetics; Peptic Ulcer; Ranitidine | 1983 |
Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Topics: Adult; Cimetidine; Double-Blind Method; Duodenal Ulcer; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Randomized Controlled Trials as Topic; Ranitidine; Reproducibility of Results; Stomach Ulcer; Time Factors; Wound Healing | 1995 |
[The effect of H2-receptor blockers (cimetidine and ranitidin) on parotid gland secretion and salivary carbonic anhydrase activity in the rat].
Topics: Animals; Carbonic Anhydrase Inhibitors; Cimetidine; Disease Models, Animal; Esophagitis, Peptic; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Parotid Gland; Ranitidine; Rats; Saliva; Secretory Rate | 1993 |
Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Anti-Ulcer Agents; Esophagitis, Peptic; Humans; Lansoprazole; Omeprazole; Ranitidine | 1993 |
The changing role of H2-receptor antagonists in acid-related diseases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Dyspepsia; Enzyme Inhibitors; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1996 |
Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disorders.
Topics: Administration, Oral; Cost-Benefit Analysis; Drug Interactions; Duodenal Ulcer; Economics, Pharmaceutical; Esophagitis, Peptic; Forecasting; Formularies as Topic; Helicobacter pylori; Humans; Infusions, Intravenous; Models, Econometric; Ranitidine; Treatment Outcome | 1994 |
[Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Cost-Benefit Analysis; Enzyme Inhibitors; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine | 2000 |
[H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Duodenal Ulcer; Enzyme Inhibitors; Esophagitis, Peptic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Stomach Ulcer; Sulfoxides | 2001 |
[Cause and prevention of nocturnal gastric acid breakthrough].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Circadian Rhythm; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Esophagitis, Peptic; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Proton Pumps; Rabeprazole; Ranitidine | 2002 |
Controlled clinical trials of omeprazole in the long-term management of reflux disease.
Topics: Administration, Oral; Australia; Belgium; Biopsy; Double-Blind Method; Endoscopy, Gastrointestinal; Esophagitis, Peptic; France; Gastrins; Humans; Multicenter Studies as Topic; Omeprazole; Randomized Controlled Trials as Topic; Ranitidine; Recurrence; Scandinavian and Nordic Countries | 1992 |
Safety experience from long-term treatment with omeprazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cimetidine; Clinical Trials as Topic; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine | 1992 |
[Therapy with H2 receptor antagonists in childhood. Use of ranitidine in duodenal and gastric ulcer and reflux esophagitis].
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Duodenal Ulcer; Esophagitis, Peptic; Humans; Infant; Infusions, Intravenous; Metabolic Clearance Rate; Ranitidine; Stomach Ulcer | 1992 |
Famotidine in gastroesophageal reflux disease (GERD).
Topics: Cimetidine; Esophagitis, Peptic; Famotidine; Gastroesophageal Reflux; Humans; Ranitidine | 1992 |
Role of sucralfate in peptic disease.
Topics: Cimetidine; Dyspepsia; Esophagitis, Peptic; Gastritis; Humans; Peptic Ulcer; Ranitidine; Recurrence; Stress, Physiological; Sucralfate; Wound Healing | 1992 |
Ranitidine and depression.
Topics: Aged; Depressive Disorder; Esophagitis, Peptic; Female; Humans; Life Change Events; Ranitidine; Recurrence; Risk Factors; Sick Role; Stomach Ulcer; Substance Withdrawal Syndrome | 1991 |
[Ranitidine: a new histamine H2 receptor blockader].
Topics: Animals; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage; Ranitidine | 1986 |
The medical therapy of reflux oesophagitis.
Topics: Antacids; Bethanechol; Bethanechol Compounds; Cimetidine; Cisapride; Domperidone; Esophagitis, Peptic; Gastroesophageal Reflux; Humans; Metoclopramide; Omeprazole; Piperidines; Ranitidine; Sucralfate | 1987 |
Treatment of reflux oesophagitis with H2-receptor antagonists.
Topics: Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Ranitidine; Time Factors | 1988 |
104 trial(s) available for ranitidine and Esophagitis, Peptic
Article | Year |
---|---|
Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies.
Topics: Adult; Aged; Analysis of Variance; Anti-Ulcer Agents; Asthma; Bronchodilator Agents; Esophagitis, Peptic; Esophagoscopy; Female; Fundoplication; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Peak Expiratory Flow Rate; Placebo Effect; Ranitidine; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome | 2003 |
[Therapeutic effect of low-dose omeprazole vs. standard-dose ranitidine in mild to moderate reflux esophagitis].
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Esophagitis, Peptic; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Ranitidine | 2004 |
[A randomized, comparative study of rabeprazole vs. ranitidine maintenance therapies for reflux esophagitis--multicenter study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Rabeprazole; Ranitidine | 2005 |
[A randomized, prospective, comparative, multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine | 2006 |
Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
Topics: Adolescent; Child; Child, Preschool; Circadian Rhythm; Double-Blind Method; Drug Synergism; Esophagitis, Peptic; Female; Gastric Acid; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Infant; Male; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Severity of Illness Index; Treatment Outcome | 2006 |
The effect of over-the-counter ranitidine 75 mg on night-time heartburn in patients with erosive oesophagitis on daily proton pump inhibitor maintenance therapy.
Topics: Esophagitis, Peptic; Gastric Acid; Heartburn; Histamine H2 Antagonists; Humans; Periodicity; Proton Pump Inhibitors; Ranitidine | 2006 |
Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Topics: Adolescent; Anti-Ulcer Agents; Child; Child, Preschool; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Male; Omeprazole; Ranitidine; Recurrence | 2007 |
[Cimetidine and ranitidine in the treatment of reflux esophagitis].
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Random Allocation; Ranitidine; Time Factors | 1984 |
[Cimetidine 2 X 400 mg in the treatment of reflux esophagitis?].
Topics: Cimetidine; Clinical Trials as Topic; Esophagitis, Peptic; Humans; Ranitidine | 1984 |
Comparison between ranitidine and cimetidine in the treatment of reflux oesophagitis.
Topics: Cimetidine; Double-Blind Method; Drug Evaluation; Esophagitis, Peptic; Female; Humans; Male; Random Allocation; Ranitidine | 1984 |
[Cimetidine versus ranitidine in the treatment of peptic esophagitis].
Topics: Adult; Aged; Anti-Ulcer Agents; Cimetidine; Drug Evaluation; Esophagitis, Peptic; Female; Furans; Guanidines; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine; Time Factors | 1983 |
[H2-blockers in reflux-esophagitis].
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine | 1983 |
Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis.
Topics: Adult; Anti-Ulcer Agents; Clinical Trials as Topic; Esophagitis, Peptic; Female; Furans; Humans; Male; Metoclopramide; Middle Aged; Ranitidine | 1983 |
Treatment of reflux oesophagitis with ranitidine.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Female; Humans; Male; Middle Aged; Ranitidine | 1983 |
Ranitidine and placebo in the treatment of reflux oesophagitis. A double-blind randomized trial.
Topics: Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Female; Humans; Male; Middle Aged; Random Allocation; Ranitidine; Tablets; Time Factors | 1983 |
[Ranitidine].
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Esophagitis, Peptic; Humans; Ranitidine | 1984 |
Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study.
Topics: Adult; Aged; Antacids; Clinical Trials as Topic; Double-Blind Method; Endoscopy; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Placebos; Ranitidine | 1984 |
A comparison of five maintenance therapies for reflux esophagitis.
Topics: Adult; Anti-Ulcer Agents; Cisapride; Disease-Free Survival; Drug Therapy, Combination; Esophagitis, Peptic; Esophagoscopy; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Piperidines; Prospective Studies; Ranitidine; Recurrence; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 1995 |
[Comparison of the cost-efficacy ratio of omeprazole and ranitidine in the treatment of reflux esophagitis].
Topics: Anti-Ulcer Agents; Endoscopy, Digestive System; Esophagitis, Peptic; Female; Health Care Costs; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Radiography; Ranitidine | 1995 |
Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Double-Blind Method; Esophagitis, Peptic; Follow-Up Studies; H(+)-K(+)-Exchanging ATPase; Headache; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 1995 |
A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Alcohol Drinking; Anti-Ulcer Agents; Caffeine; Double-Blind Method; Drug Evaluation; Esophagitis, Peptic; Female; Gastroscopy; Humans; Lansoprazole; Longitudinal Studies; Male; Omeprazole; Proton Pump Inhibitors; Ranitidine; Smoking | 1995 |
Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1995 |
Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Esophagitis, Peptic; Female; Gastric Mucosa; Gastrins; Humans; Life Tables; Male; Middle Aged; Omeprazole; Parietal Cells, Gastric; Prognosis; Prospective Studies; Ranitidine; Recurrence; Regression Analysis; Remission Induction; Scandinavian and Nordic Countries; Time Factors | 1994 |
Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis.
Topics: Adult; Aged; Aged, 80 and over; Cimetidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Esophagoscopy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome; Wound Healing | 1994 |
Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Double-Blind Method; Esophagitis, Peptic; Female; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Time Factors | 1993 |
[The effectiveness of ranitidine in non-ulcer dyspepsia (functional dyspepsia) in comparison with an antacid].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aluminum Hydroxide; Antacids; Drug Combinations; Dyspepsia; Esophagitis, Peptic; Female; Humans; Magnesium Hydroxide; Male; Middle Aged; Ranitidine; Silicic Acid | 1994 |
Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
Topics: Adult; Aged; Anti-Ulcer Agents; Cisapride; Double-Blind Method; Drug Therapy, Combination; Esophageal Diseases; Esophagitis, Peptic; Esophagogastric Junction; Female; Gastric Acid; Gastrointestinal Motility; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Monitoring, Physiologic; Muscle Contraction; Muscle, Smooth; Piperidines; Ranitidine; Time Factors | 1993 |
Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Esophagus; Female; Humans; Hyperplasia; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Time Factors | 1994 |
Two different dose regimens of cisapride in the treatment of reflux oesophagitis: a double-blind comparison with ranitidine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aluminum Hydroxide; Antacids; Cisapride; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Dyspepsia; Esophagitis, Peptic; Esophagoscopy; Humans; Magnesium Hydroxide; Middle Aged; Piperidines; Ranitidine; Serotonin Antagonists; Single-Blind Method | 1993 |
Effects of ranitidine 150 mg four times a day on 24-hour intragastric acidity and 24-hour plasma gastrin concentration.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Male; Ranitidine | 1994 |
Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
Topics: Adolescent; Child; Child, Preschool; Esophagitis, Peptic; Esophagus; Female; Gastric Acidity Determination; Gastrins; Humans; Infant; Male; Omeprazole; Ranitidine | 1993 |
Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis.
Topics: Adult; Antacids; Circadian Rhythm; Drug Therapy, Combination; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Metoclopramide; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1993 |
Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Anti-Ulcer Agents; Esophagitis, Peptic; Humans; Lansoprazole; Omeprazole; Ranitidine | 1993 |
Efficacy of twice daily doses of 40 or 20 milligrams famotidine or 150 milligrams ranitidine for treatment of patients with moderate to severe erosive esophagitis. Famotidine Erosive Esophagitis Study Group.
Topics: Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Famotidine; Female; Humans; Male; Middle Aged; Ranitidine | 1993 |
Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cisapride; Double-Blind Method; Drug Therapy, Combination; Esophagitis, Peptic; Esophagoscopy; Female; Follow-Up Studies; Histamine H2 Antagonists; Humans; Logistic Models; Male; Middle Aged; Piperidines; Ranitidine; Serotonin Antagonists; Treatment Outcome | 1995 |
Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Topics: Dopamine Antagonists; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Esophagitis, Peptic; Female; Histamine H2 Antagonists; Humans; Male; Metoclopramide; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1996 |
A comparative study of cisapride and ranitidine at controlling oesophageal acid exposure in erosive oesophagitis.
Topics: Adult; Anti-Ulcer Agents; Cisapride; Esophagitis, Peptic; Female; Gastric Acid; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Male; Middle Aged; Piperidines; Ranitidine | 1995 |
Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Diarrhea; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastritis; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine | 1996 |
A randomized blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis.
Topics: Aged; Anti-Ulcer Agents; Chi-Square Distribution; Chronic Disease; Combined Modality Therapy; Dilatation; Esophageal Stenosis; Esophagitis, Peptic; Esophagus; Humans; Omeprazole; Radiography; Ranitidine | 1996 |
Gastro-oesophageal reflux disease in The Netherlands. Results of a multicentre pH study.
Topics: Chi-Square Distribution; Dose-Response Relationship, Drug; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Monitoring, Physiologic; Netherlands; Ranitidine; Treatment Outcome | 1996 |
Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Esophagitis, Peptic; Esophagoscopy; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Ranitidine; Regression Analysis; Treatment Outcome | 1996 |
Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
Topics: Antacids; Anti-Ulcer Agents; Dilatation; Esophageal Stenosis; Esophagitis, Peptic; Female; Follow-Up Studies; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Recurrence; Time Factors | 1996 |
Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antacids; Anti-Ulcer Agents; Double-Blind Method; Drug Resistance; Esophagitis, Peptic; Esophagoscopy; Fasting; Female; Follow-Up Studies; Gastrins; Heartburn; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ranitidine; Safety; Sleep; Sleep Stages; Ulcer; Wound Healing | 1997 |
[Maintenance therapy in reflux esophagitis].
Topics: Adult; Anti-Ulcer Agents; Cisapride; Drug Therapy, Combination; Esophagitis, Peptic; Esophagoscopy; Female; Humans; Long-Term Care; Male; Middle Aged; Omeprazole; Piperidines; Ranitidine; Treatment Outcome | 1997 |
Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastroscopy; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1997 |
Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Topics: Adult; Aged; Biopsy; Cimetidine; Drug Administration Schedule; Drug Resistance; Enzyme Inhibitors; Esophagitis, Peptic; Esophagus; Female; Follow-Up Studies; Gastric Mucosa; Gastrins; Gastroscopy; Histamine H2 Antagonists; Humans; Hyperplasia; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Treatment Outcome; Wound Healing | 1997 |
Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Treatment Outcome | 1998 |
Cost and quality effects of treating erosive oesophagitis. A re-evaluation.
Topics: Antacids; Anti-Ulcer Agents; Cost of Illness; Costs and Cost Analysis; Decision Trees; Esophagitis, Peptic; Humans; Insurance, Health; Omeprazole; Ranitidine; Treatment Outcome | 1995 |
Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Topics: Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Recurrence; Time Factors | 1999 |
On demand therapy of reflux oesophagitis--a prospective study of symptoms, patient satisfaction and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Esophagitis, Peptic; Famotidine; Female; Gastric Acidity Determination; Heartburn; Humans; Male; Middle Aged; Norway; Omeprazole; Patient Satisfaction; Prospective Studies; Quality of Life; Ranitidine; Socioeconomic Factors | 1999 |
Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Double-Blind Method; Endoscopy; Eructation; Esophagitis, Peptic; Female; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pain; Ranitidine; Time Factors | 1999 |
Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Severity of Illness Index; South Africa; Sulfoxides; Treatment Outcome | 2000 |
Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Secondary Prevention; Sulfoxides | 2001 |
Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Probability; Ranitidine; Risk Assessment; Sulfoxides; Treatment Outcome; Wound Healing | 2002 |
The effect of combined therapy with ranitidine and pirenzepine in the treatment of reflux oesophagitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Pirenzepine; Ranitidine | 1992 |
Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.
Topics: Adult; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Esophagitis, Peptic; Esophagus; Female; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Prognosis; Ranitidine; Time Factors; Treatment Outcome | 1992 |
A comparison of the clinical efficacy of ranitidine and sucralfate in reflux esophagitis.
Topics: Adult; Aged; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Patient Compliance; Ranitidine; Sucralfate | 1992 |
[Treatment of acid-related diseases of the gastrointestinal tract. Observations in patients receiving a single evening dose of 300 mg ranitidine].
Topics: Adult; Aged; Drug Administration Schedule; Duodenal Ulcer; Esophagitis, Peptic; Female; Gastritis; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine | 1992 |
Combination therapy of sucralfate and ranitidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Ranitidine; Sucralfate | 1992 |
Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
Topics: Barrett Esophagus; Drug Administration Schedule; Esophagitis, Peptic; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Monitoring, Physiologic; Omeprazole; Prospective Studies; Ranitidine; Time Factors | 1992 |
A comparison of the clinical efficacy of ranitidine and sucralfate in reflux oesophagitis.
Topics: Adult; Esophagitis, Peptic; Female; Humans; Male; Ranitidine; Sucralfate | 1992 |
Long-term treatment with 300 mg ranitidine once daily after dilatation of peptic oesophageal strictures.
Topics: Aged; Dilatation; Double-Blind Method; Drug Administration Schedule; Esophageal Stenosis; Esophagitis, Peptic; Female; Humans; Male; Ranitidine | 1992 |
Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
Topics: Adult; Aged; Biopsy; Chi-Square Distribution; Esophagitis, Peptic; Esophagoscopy; Gastric Mucosa; Gastrins; Humans; Middle Aged; Omeprazole; Ranitidine; Recurrence | 1991 |
Reflux esophagitis therapy: sucralfate versus ranitidine in a double blind multicenter trial.
Topics: Administration, Oral; Adult; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Endoscopy, Gastrointestinal; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Ranitidine; Severity of Illness Index; Smoking; Steroids; Sucralfate; Wound Healing | 1991 |
Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
Topics: Adult; Aged; Double-Blind Method; Endoscopy, Gastrointestinal; Esophagitis, Peptic; Female; Gastrins; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Ranitidine | 1990 |
Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
Topics: Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Gastric Acidity Determination; Gastric Mucosa; Humans; Omeprazole; Ranitidine; Recurrence | 1990 |
Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis.
Topics: Adult; Aged; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ranitidine; Recurrence; Time Factors; Wound Healing | 1990 |
[A chance for conservative treatment of reflux disease. Can it be used preventively in malignant changes?].
Topics: Adolescent; Adult; Aged; Cisapride; Clinical Trials as Topic; Double-Blind Method; Esophageal Neoplasms; Esophagitis, Peptic; Humans; Middle Aged; Piperidines; Precancerous Conditions; Ranitidine; Serotonin Antagonists | 1990 |
[Cisapride versus ranitidine in reflux esophagitis].
Topics: Adult; Antacids; Cisapride; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Piperidines; Randomized Controlled Trials as Topic; Ranitidine; Serotonin Antagonists | 1990 |
Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime.
Topics: Adult; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Female; Humans; Male; Ranitidine | 1989 |
Comparison of Algicon and ranitidine in the therapy of reflux oesophagitis: preliminary results.
Topics: Adult; Alginates; Aluminum Hydroxide; Antacids; Bicarbonates; Carbonates; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Ranitidine | 1989 |
Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine.
Topics: Clinical Trials as Topic; Duodenal Ulcer; Esophagitis, Peptic; Follow-Up Studies; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Long-Term Care; Omeprazole; Ranitidine; Stomach Ulcer | 1989 |
Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Ranitidine | 1989 |
Sucralfate in the treatment of reflux esophagitis in adults: an update.
Topics: Adult; Esophagitis, Peptic; Female; Humans; Male; Multicenter Studies as Topic; Random Allocation; Ranitidine; Sucralfate; Time Factors | 1989 |
[Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium].
Topics: Belgium; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; France; Humans; Male; Middle Aged; Multicenter Studies as Topic; Omeprazole; Random Allocation; Ranitidine; Time Factors | 1989 |
The clinical safety of omeprazole.
Topics: Cimetidine; Clinical Trials as Topic; Esophagitis, Peptic; Humans; Liver Function Tests; Omeprazole; Peptic Ulcer; Ranitidine; Thyroid Function Tests; Zollinger-Ellison Syndrome | 1989 |
Comparison of omeprazole with ranitidine in the treatment of reflux oesophagitis.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Omeprazole; Ranitidine | 1989 |
Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.
Topics: Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine; Time Factors | 1987 |
Omeprazole versus ranitidine in erosive oesophagitis.
Topics: Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine | 1987 |
Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis.
Topics: Adult; Aged; Alcohol Drinking; Antacids; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Posture; Random Allocation; Ranitidine; Sleep; Smoking | 1987 |
[Therapeutic achlorhydria: for which diseases, when and for how long?].
Topics: Achlorhydria; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Time Factors; Zollinger-Ellison Syndrome | 1988 |
Treatment of reflux oesophagitis with H2-receptor antagonists.
Topics: Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Ranitidine; Time Factors | 1988 |
The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis.
Topics: Adult; Aged; Circadian Rhythm; Double-Blind Method; Esophagitis, Peptic; Esophagus; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Ranitidine | 1988 |
Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine; Scandinavian and Nordic Countries | 1988 |
Cisapride versus ranitidine in the treatment of reflux esophagitis.
Topics: Cisapride; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Piperidines; Random Allocation; Ranitidine | 1988 |
Medical therapy for chronic reflux esophagitis. Long-term follow-up.
Topics: Barrett Esophagus; Chronic Disease; Cimetidine; Clinical Trials as Topic; Drug Therapy, Combination; Esophagitis, Peptic; Esophagogastric Junction; Follow-Up Studies; Humans; Long-Term Care; Male; Manometry; Metoclopramide; Middle Aged; Ranitidine; Recurrence | 1987 |
Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Esophagus; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine | 1988 |
Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine; Time Factors | 1988 |
Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial.
Topics: Adult; Antacids; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Esophagus; Gastroesophageal Reflux; Heartburn; Humans; Random Allocation; Ranitidine | 1987 |
Comparison of the effect of sucralfate and ranitidine in reflux esophagitis.
Topics: Adult; Clinical Trials as Topic; Endoscopy; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Mucous Membrane; Random Allocation; Ranitidine; Sucralfate | 1987 |
Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study.
Topics: Adult; Antacids; Biopsy; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Esophagoscopy; Female; Humans; Male; Middle Aged; Random Allocation; Ranitidine | 1987 |
Reflux oesophagitis in heavy drinkers. Effect of ranitidine and alginate/metoclopramide.
Topics: Adult; Alcoholism; Alginates; Double-Blind Method; Drug Therapy, Combination; Esophagitis, Peptic; Esophagoscopy; Female; Humans; Male; Metoclopramide; Middle Aged; Random Allocation; Ranitidine | 1987 |
[Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicenter study].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine | 1986 |
Comparison of omeprazole and ranitidine in the treatment of reflux esophagitis.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Omeprazole; Random Allocation; Ranitidine; Rats | 1986 |
Ranitidine, 150 mg three times a day, in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study.
Topics: Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Endoscopy; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Ranitidine | 1986 |
Healing and relapse of reflux esophagitis during treatment with ranitidine.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Endoscopy; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Placebos; Prospective Studies; Ranitidine; Recurrence | 1986 |
[2 or 1 daily doses of ranitidine in the treatment of reflux esophagitis].
Topics: Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Esophagitis, Peptic; Esophagoscopy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Random Allocation; Ranitidine | 1986 |
Controlled comparison of ranitidine and cimetidine in patients of duodenal ulcer, gastric ulcer and reflux esophagitis: a multicentre study.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Esophagitis, Peptic; Humans; Ranitidine; Stomach Ulcer | 1986 |
Controlled comparison of ranitidine and cimetidine in patients of duodenal ulcer, gastric ulcer and reflux esophagitis: a multicentre study.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Random Allocation; Ranitidine; Stomach Ulcer | 1986 |
Esophagitis healing with ranitidine.
Topics: Adult; Esophagitis, Peptic; Female; Humans; Male; Ranitidine | 1987 |
[Etintidine versus ranitidine in the treatment of reflux esophagitis].
Topics: Drug Evaluation; Esophagitis, Peptic; Humans; Imidazoles; Ranitidine | 1986 |
Ranitidine in the management of gastro-oesophageal reflux disease.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Ranitidine | 1985 |
Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial.
Topics: Adult; Aged; Aluminum Hydroxide; Antacids; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Esophagitis, Peptic; Female; Humans; Magnesium; Magnesium Hydroxide; Male; Middle Aged; Placebos; Random Allocation; Ranitidine | 1985 |
Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis.
Topics: Clinical Trials as Topic; Domperidone; Drug Therapy, Combination; Endoscopy; Esophagitis, Peptic; Humans; Ranitidine | 1985 |
53 other study(ies) available for ranitidine and Esophagitis, Peptic
Article | Year |
---|---|
New insight into oseophageal injury and protection in physiologically relevant animal models.
Topics: Animals; Atropine; Cytokines; Disease Models, Animal; Esophagitis, Peptic; Esophagus; Histamine H2 Antagonists; Hyperglycemia; Intestinal Mucosa; Mouth Mucosa; Muscarinic Antagonists; Nitric Oxide; Nitric Oxide Synthase; Ranitidine; Rats | 2014 |
Expression of NADPH-d in the vagal nuclei of the chronic esophagitis model in rats.
Topics: Animals; Brain Stem; Disease Models, Animal; Esophagitis, Peptic; Gastroesophageal Reflux; Histamine H2 Antagonists; Male; Motor Neurons; NADPH Dehydrogenase; Ranitidine; Rats, Sprague-Dawley; Solitary Nucleus; Vagus Nerve | 2014 |
Effects of Morinda citrifolia aqueous fruit extract and its biomarker scopoletin on reflux esophagitis and gastric ulcer in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetic Acid; Animals; Biomarkers; Cisapride; Disease Models, Animal; Esophagitis, Peptic; Fruit; Gastric Acid; Gastric Mucosa; Gastrointestinal Agents; Gastrointestinal Transit; Lansoprazole; Male; Morinda; Pepsin A; Plant Extracts; Ranitidine; Rats; Rats, Wistar; Scopoletin; Serotonin; Stomach; Stomach Ulcer; Thailand | 2011 |
"Proton-pump inhibitor-first" strategy versus "step-up" strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Cost-Benefit Analysis; Decision Support Techniques; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Japan; Lansoprazole; Models, Statistical; Omeprazole; Proton Pump Inhibitors; Ranitidine | 2005 |
Treatment interruptus: the need for withdrawal.
Topics: Anti-Ulcer Agents; Child; Esophagitis, Peptic; Gastroesophageal Reflux; Humans; Omeprazole; Ranitidine | 2007 |
[H2 receptor blockaders: domains for oral use. Indications for cimetidine and ranitidine in gastroenterology].
Topics: Administration, Oral; Cimetidine; Duodenitis; Esophagitis, Peptic; Exocrine Pancreatic Insufficiency; Gastritis; Gastrointestinal Diseases; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage; Ranitidine; Zollinger-Ellison Syndrome | 1984 |
Treatment of reflux oesophagitis.
Topics: Alginates; Aluminum Hydroxide; Antacids; Anti-Ulcer Agents; Barrett Esophagus; Bethanechol Compounds; Bicarbonates; Carbenoxolone; Cimetidine; Constriction, Pathologic; Domperidone; Drug Combinations; Esophagitis, Peptic; Esophagogastric Junction; Furans; Histamine H2 Antagonists; Humans; Metoclopramide; Ranitidine; Silicates; Silicic Acid | 1982 |
[Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
Topics: Esophagitis, Peptic; Female; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Imidazoles; Male; Middle Aged; Ranitidine | 1983 |
[Therapy of esophageal reflux disease].
Topics: Antacids; Bethanechol Compounds; Cimetidine; Esophagitis, Peptic; Furans; Gastroesophageal Reflux; Humans; Ranitidine | 1982 |
Interstitial nephritis after cimetidine but not ranitidine.
Topics: Aged; Cimetidine; Esophagitis, Peptic; Furans; Guanidines; Humans; Male; Nephritis, Interstitial; Ranitidine | 1983 |
[Treatment of reflux esophagitis with ranitidine. A multicentric prospective study].
Topics: Anti-Ulcer Agents; Esophagitis, Peptic; Female; Furans; Humans; Male; Middle Aged; Prospective Studies; Ranitidine | 1982 |
Treatment of reflux oesophagitis.
Topics: Cimetidine; Esophagitis, Peptic; Humans; Ranitidine | 1983 |
[Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
Topics: Algorithms; Anti-Ulcer Agents; Barrett Esophagus; Esophagitis, Peptic; Esophagoscopy; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Ranitidine | 1995 |
Esophageal aperistalsis and gastroesophageal reflux disorder: return of peristalsis after H2-blocker therapy.
Topics: Esophagitis, Peptic; Esophagus; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Peristalsis; Ranitidine | 1995 |
Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy.
Topics: Abdominal Pain; Adolescent; Child; Chronic Disease; Drug Resistance; Esophagitis, Peptic; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Prospective Studies; Ranitidine | 1995 |
Prolonged remission of oesophagitis does not alter the magnitude of oesophageal acid exposure.
Topics: Adult; Aged; Esophagitis; Esophagitis, Peptic; Esophagus; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1994 |
Assessing the cost-effectiveness of medical treatments in acid-related diseases. The Markov chain approach applied to a comparison between intermittent and maintenance treatment of reflux esophagitis.
Topics: Cost of Illness; Cost-Benefit Analysis; Decision Support Techniques; Esophagitis, Peptic; Humans; Markov Chains; Omeprazole; Ranitidine; Recurrence; Sweden | 1993 |
Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy.
Topics: Adult; Aged; Aged, 80 and over; Barrett Esophagus; Dose-Response Relationship, Drug; Duodenal Ulcer; Esophagitis, Peptic; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Male; Middle Aged; Ranitidine | 1994 |
Unusual presentation of mucosal hypersensitivity secondary to gastroesophageal reflux disease.
Topics: Adolescent; Deglutition Disorders; Enteral Nutrition; Eosinophils; Esophagitis, Peptic; Esophagus; Follow-Up Studies; Gastroesophageal Reflux; Humans; Male; Mucous Membrane; Omeprazole; Ranitidine; Vomiting | 1993 |
Maintenance therapies for reflux esophagitis.
Topics: Anti-Ulcer Agents; Cisapride; Drug Therapy, Combination; Esophagitis, Peptic; Humans; Omeprazole; Patient Compliance; Piperidines; Ranitidine | 1996 |
Peptic esophageal stricture: is surgery still necessary?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cimetidine; Combined Modality Therapy; Dilatation; Esophageal Stenosis; Esophagitis, Peptic; Female; Follow-Up Studies; Fundoplication; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome | 1996 |
Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
Topics: Antacids; Anti-Ulcer Agents; Dilatation; Esophageal Stenosis; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine | 1996 |
Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
Topics: Animals; Anti-Ulcer Agents; Enzyme Inhibitors; Esophagitis, Peptic; Gastric Acid; Gastric Fistula; Gastric Mucosa; Histamine H2 Antagonists; Imidazoles; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Pyridines; Ranitidine; Rats; Rats, Sprague-Dawley | 1997 |
Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Case-Control Studies; Cost-Benefit Analysis; Decision Support Techniques; Delphi Technique; Drug Costs; Enzyme Inhibitors; Esophagitis, Peptic; Follow-Up Studies; Gastroenterology; Histamine H2 Antagonists; Humans; Lansoprazole; Medicare; Omeprazole; Probability; Proton Pump Inhibitors; Quality of Life; Randomized Controlled Trials as Topic; Ranitidine; Recurrence; Relative Value Scales; Sensitivity and Specificity; United States; Value of Life | 1997 |
PPIs vs H2RAs for erosive reflux esophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Cost-Benefit Analysis; Enzyme Inhibitors; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Lansoprazole; Markov Chains; Omeprazole; Ranitidine; Recurrence; Reproducibility of Results | 1998 |
Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats.
Topics: Animals; Anti-Ulcer Agents; Cholestyramine Resin; Esophagitis, Peptic; Female; Gastric Mucosa; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar; Sucralfate; Time Factors | 1999 |
Cost effectiveness of rabeprazole versus generic ranitidine for symptom resolution in patients with erosive esophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cost-Benefit Analysis; Decision Trees; Drug Costs; Drugs, Generic; Enzyme Inhibitors; Esophagitis, Peptic; Gastroesophageal Reflux; Health Care Costs; Histamine H2 Antagonists; Humans; Managed Care Programs; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; United States | 2000 |
Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Blotting, Western; Cyclooxygenase 2; DNA; DNA-Binding Proteins; Electrophoresis, Polyacrylamide Gel; Esophagitis, Peptic; Esophagus; Gastric Acid; Glutathione; I-kappa B Proteins; Inflammation; Isoenzymes; Lipid Peroxides; Male; Malondialdehyde; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Pharmaceutical Preparations; Plant Extracts; Prostaglandin-Endoperoxide Synthases; Ranitidine; Rats; Rats, Sprague-Dawley | 2001 |
Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Antioxidants; Barrett Esophagus; Carcinoma; Chemoprevention; Chronic Disease; Disease Models, Animal; Esophageal Neoplasms; Esophagitis, Peptic; Esophagus; Glutathione; Immunohistochemistry; Male; Malondialdehyde; Metaplasia; Mucous Membrane; NF-kappa B; Oxidative Stress; Proliferating Cell Nuclear Antigen; Ranitidine; Rats; Rats, Sprague-Dawley | 2001 |
Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Blotting, Western; Dose-Response Relationship, Drug; Esophagitis, Peptic; Gastric Acid; Glutathione; Male; Malondialdehyde; NF-kappa B; Oxidative Stress; Pharmaceutical Preparations; Plant Extracts; Ranitidine; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2001 |
[A study on reflux esophagitis--clinical nonsense].
Topics: Cost-Benefit Analysis; Esophagitis, Peptic; Humans; Omeprazole; Ranitidine | 1992 |
[Prognostic markers in reflux esophagitis better than wrapped up recommendations].
Topics: Biomarkers; Esophagitis, Peptic; Humans; Omeprazole; Prognosis; Ranitidine | 1992 |
[Omeprazole is more cost-effective than ranitidine in reflux esophagitis].
Topics: Cost-Benefit Analysis; Drug Costs; Esophagitis, Peptic; Humans; Omeprazole; Ranitidine | 1992 |
24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis.
Topics: Adult; Aged; Aged, 80 and over; Circadian Rhythm; Esophagitis, Peptic; Female; Gastric Acidity Determination; Gastrins; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1991 |
Pattern of acid reflux in patients with reflux esophagitis 'resistant' to H2-receptor antagonists.
Topics: Esophagitis, Peptic; Famotidine; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Monitoring, Physiologic; Ranitidine; Time Factors | 1990 |
[Reflux esophagitis: therapy with H2-blockers, and motility disorders].
Topics: Esophagitis, Peptic; Esophagoscopy; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Ranitidine | 1991 |
Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
Topics: Drug Resistance; Esophagitis, Peptic; Gastrins; Humans; Omeprazole; Peptic Ulcer; Ranitidine; Time Factors | 1990 |
Daytime reduction of gastro-oesophageal reflux after healing of oesophagitis and its value as an indicator of favourable response to maintenance treatment.
Topics: Circadian Rhythm; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Prospective Studies; Ranitidine; Recurrence | 1990 |
Gastric emptying in non-responders to H2-receptor antagonists.
Topics: Adult; Aged; Drug Resistance; Esophagitis, Peptic; Female; Gastric Emptying; Gastritis; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Peptic Ulcer; Ranitidine; Stomach Diseases | 1990 |
Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
Topics: Adult; Esophagitis, Peptic; Esophagus; Female; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Ranitidine; Stomach; Time Factors | 1990 |
High doses of ranitidine in patients with reflux oesophagitis.
Topics: Adult; Aged; Esophagitis, Peptic; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Male; Middle Aged; Omeprazole; Ranitidine | 1990 |
High dose famotidine in ranitidine resistant severe oesophagitis: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Barrett Esophagus; Drug Administration Schedule; Esophagitis, Peptic; Famotidine; Female; Humans; Male; Middle Aged; Pilot Projects; Ranitidine | 1990 |
Frequent non-response to histamine H2-receptor antagonists in cirrhotics.
Topics: Anti-Ulcer Agents; Cimetidine; Esophagitis, Peptic; Famotidine; Female; Gastric Acidity Determination; Gastritis; Histamine H2 Antagonists; Humans; Liver Cirrhosis; Male; Middle Aged; Peptic Ulcer; Ranitidine; Thiazoles | 1989 |
Evaluation of gastroesophageal reflux as a cause of idiopathic hoarseness.
Topics: Adult; Aged; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Hoarseness; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Monitoring, Physiologic; Ranitidine; Voice Quality | 1989 |
Ranitidine in the treatment of reflux oesophagitis in pregnancy.
Topics: Adult; Esophagitis, Peptic; Female; Fetal Blood; Humans; Pregnancy; Pregnancy Complications; Ranitidine | 1989 |
Efficacy of sucralfate in refractory reflux esophagitis. Results of a pilot study.
Topics: Aged; Cimetidine; Domperidone; Drug Therapy, Combination; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Pilot Projects; Ranitidine; Sucralfate; Time Factors | 1989 |
[Meta-analysis in clinical research].
Topics: Clinical Trials as Topic; Esophagitis, Peptic; Humans; Meta-Analysis as Topic; Ranitidine | 1988 |
[Cimetidine or ranitidine?].
Topics: Cimetidine; Cytochrome P-450 Enzyme Inhibitors; Esophagitis, Peptic; Gynecomastia; Humans; Male; Peptic Ulcer; Ranitidine; Zollinger-Ellison Syndrome | 1986 |
[Reduced suppression of gastric acid by ranitidine in severe reflux esophagitis. A pilot study].
Topics: Adult; Aged; Dose-Response Relationship, Drug; Esophagitis, Peptic; Female; Gastric Acidity Determination; Humans; Male; Middle Aged; Omeprazole; Pilot Projects; Ranitidine | 1988 |
Oesophageal function before, during, and after healing of erosive oesophagitis.
Topics: Adult; Aged; Esophagitis, Peptic; Esophagogastric Junction; Esophagus; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Peristalsis; Ranitidine | 1988 |
Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment.
Topics: Adult; Aged; Duodenal Ulcer; Esophagitis, Peptic; Female; Gastrins; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer; Time Factors | 1988 |
H2 antagonists in the treatment of reflux oesophagitis: can physiological studies predict the response?
Topics: Adolescent; Adult; Aged; Deglutition; Esophagitis, Peptic; Esophagus; Female; Gastrins; Gastrointestinal Motility; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Peristalsis; Ranitidine | 1987 |
The Zollinger-Ellison syndrome: a review of the St Vincent's Hospital, Melbourne experience.
Topics: Adult; Aged; Cimetidine; Duodenal Ulcer; Esophagitis, Peptic; Female; Gastric Acid; Humans; Hypercalcemia; Male; Middle Aged; Ranitidine; Zollinger-Ellison Syndrome | 1985 |